Cargando…

From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia

Despite documented laboratory and clinical benefits of hydroxyurea for children with sickle cell anemia (SCA), the drug's long-term safety and efficacy remains poorly defined. The HUSOFT trial and extension study examined feasibility, toxicity, and hematological efficacy of hydroxyurea in infan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hankins, Jane S., Aygun, Banu, Nottage, Kerri, Thornburg, Courtney, Smeltzer, Matthew P., Ware, Russell E., Wang, Winfred C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2014
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603125/ https://www.ncbi.nlm.nih.gov/pubmed/25526439 http://dx.doi.org/10.1097/MD.0000000000000215

Ejemplares similares

Hydroxyurea Use and Hospitalization Trends in a Comprehensive Pediatric Sickle Cell Program
por: Nottage, Kerri A., et al.
Publicado: (2013)

The role of hydroxyurea to prevent silent stroke in sickle cell disease: Systematic review and meta-analysis
por: Hasson, Carla, et al.
Publicado: (2019)

Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia
por: Sheehan, Vivien A., et al.
Publicado: (2014)

Intensive hydroxyurea dosing in very young children with sickle cell anemia
por: Wang, Winfred C., et al.
Publicado: (2023)

Nosocomial infections in sickle cell anemia patients: Prevention through multi-disciplinary approach: A review
por: Obeagu, Emmanuel Ifeanyi, et al.
Publicado: (2023)

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial
por: McGann, Patrick T., et al.
Publicado: (2015)

Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot)
por: Sakamoto, Kenichi, et al.
Publicado: (2022)

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapy
por: Dhar, Arushi, et al.
Publicado: (2021)

Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia
por: Schaefer, Beverly A., et al.
Publicado: (2016)

Understanding Sickle cell disease: Causes, symptoms, and treatment options
por: Elendu, Chukwuka, et al.
Publicado: (2023)

The need to screen for anemia in exercising women
por: Dugan, Cory, et al.
Publicado: (2021)

Environmental Influences on Daily Emergency Admissions in Sickle-Cell Disease Patients
por: Mekontso Dessap, Armand, et al.
Publicado: (2014)

Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report
por: Rozi, Waail, et al.
Publicado: (2021)

Retinopathy in Egyptian patients with sickle cell disease: A cross-sectional study
por: Hassan, Tamer, et al.
Publicado: (2021)

Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance
por: Mathias, Joacy G., et al.
Publicado: (2021)

Understanding multi-level barriers to medication adherence among adults living with sickle cell disease
por: Egiebor, Ivie C., et al.
Publicado: (2023)

Hydroxyurea and sickle cell anemia: effect on quality of life
por: Ballas, Samir K, et al.
Publicado: (2006)

The influence of hydroxyurea on oxidative stress in sickle cell anemia
por: Torres, Lidiane de Souza, et al.
Publicado: (2012)

Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial
por: Puri, Latika, et al.
Publicado: (2021)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Autoimmune hemolytic anemia in hospitalized patients: 450 patients and their red blood cell transfusions
por: Chen, Chunxia, et al.
Publicado: (2020)

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
por: Rankine-Mullings, Angela, et al.
Publicado: (2023)

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020)

Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report
por: Li, Xiang, et al.
Publicado: (2020)

Human leukocyte antigen-DRB1 gene polymorphism and aplastic anemia: A meta-analysis
por: Liang, Lijie, et al.
Publicado: (2023)

Quality of care in sickle cell disease: Cross-sectional study and development of a measure for adults reporting on ambulatory and emergency department care
por: Evensen, Christian T., et al.
Publicado: (2016)

Risk factor analysis of autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in children
por: Chang, Tsung-Yen, et al.
Publicado: (2016)

Bochdalek hernia with Diamond-Blackfan anemia associated with RPS19 gene mutation: A case report
por: Yoo, Ye Seul, et al.
Publicado: (2019)

Clinical analysis of 20 patients with non-Hodgkin lymphoma and autoimmune hemolytic anemia: A retrospective study
por: Zhou, Ji-cheng, et al.
Publicado: (2020)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Erythropoietin combined with traditional Chinese medicine for chemotherapy-induced anemias: A protocol of systematic review and meta-analysis
por: Wang, Long-Feng, et al.
Publicado: (2020)

Fatal fulminant hemolysis-associated pulmonary embolism in mixed-type autoimmune hemolytic anemia: A case report
por: Imataki, Osamu, et al.
Publicado: (2020)

Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia"
por: van Beers, Eduard Johannes, et al.
Publicado: (2012)

Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia
por: Keikhaei, Bijan, et al.
Publicado: (2016)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

An unusual association between hemophagocytic lymphohistiocytosis, mixed connective tissue disease, and autoimmune hemolytic anemia: A case report
por: Kelkar, Amar H., et al.
Publicado: (2017)

Aplastic anemia from past to the present: A bibliometric analysis with research trends and global productivity during 1980 to 2022
por: Bulduk, Tuba
Publicado: (2023)

Autoimmune Myelofibrosis and Systemic Lupus Erythematosus in a Middle-Aged Male Presenting Only with Severe Anemia: A case report
por: Pundole, Xerxes, et al.
Publicado: (2015)

Long-term effects of hematopoietic growth factors in aplastic anemia patients treated with immunosuppression: Meta-analysis of randomized controlled trials
por: Wang, Anzi, et al.
Publicado: (2022)

Prevalence of Vitamin D Deficiency in Sickle Cell Disease: A Systematic Review
por: Nolan, Vikki G., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_73d895aj2egqrl61d5snf7easq